Popular Articles
Natural Remedies

Northamptonshire Animal Feed Company Fined After Worker Falls From Height
The Health and Safety Executive (HSE) is reminding employers of their duties to the safety of staff following an incident in Kettering where an employee fell six foot and suffered serious injury.
generic viagra online
Docs Plan Strike, Issue Own Declaration Of Independence
On Independence Day, Doctors on Strike for Freedom in Medicine will take on the mission of preserving, protecting, and promoting freedom in healthcare. This nonprofit organization"s web site (http://www.doctorsonstrike.com) states that their most pressing goal is to mobilize doctors to go on strike against any new government healthcare plans. Their long-term objective is to supply healthcare providers with intellectual ammunition to win the "philosophical war" against statism in medicine.
News of the day
Radiotherapy Link To Breast Cancer And Heart Disease Found
Scientists have found a way to identify breast cancer patients at risk of heart disease after radiotherapy, according to a report published yesterday.
Mental Health

Roche Launches Complete Detection Kit For Influenza A /H1N1 On LightCycler(R) System

Roche Applied Science announced the availability of a new detection kit for the Influenza A/H1N1 virus. The detection kit is offered for use in life science research. Roche currently is filing to get approval of the local health authorities worldwide for use of the kit in emergency situations. The kit runs on Roche÷´s LightCycler® 480 II, 2.0, and 1.5 systems. It was evaluated with virus positive sample materials and selectively identifies the new Influenza A H1N1 virus. Compared with other detection kits, it features a couple of advantages in regard to efficiency and handling. "The design of the new detection kits benefitted very much from information we got out of our manifold research cooperations. We are glad of our contribution in supplying fast and reliable tools for the detection of Influenza A/H1N1 to the research community," said Manfred Baier, Head of Roche Applied Science. Applied Science offers a variety of platforms that can be used to help identify the Influenza A H1N1 virus, including Nucleic Acid Purification, Real-Time PCR, Microarrays and Sequencing systems. The company is in close contact with various research institutions and test centers worldwide providing assistance in the detection and characterization of Influenza A H1N1 virus. Currently, there is no human vaccine on the market that protects against Influenza A H1N1 infection. Standard therapy for the disease includes treatment with antiviral drugs like Tamiflu or Relenza. For more information on Influenza A H1N1 please visit www.who.int. Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):